Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.130
+0.010 (0.89%)
May 28, 2026, 3:04 PM EDT - Market open
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $15.58 million as of May 28, 2026. Its market cap has decreased by -2.01% in one year.
Market Cap
15.58M
Enterprise Value
12.18M
1-Year Change
-2.01%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $15.58M, a decrease of -86.49%. That is a compound annual growth rate of -21.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 15.40M | 14.07% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 17.40M |
| Hoth Therapeutics | 17.30M |
| OSR Holdings | 16.73M |
| Lexaria Bioscience | 16.37M |
| Vyome Holdings | 15.93M |
| Genenta Science | 15.83M |
| Cadrenal Therapeutics | 15.42M |
| Moolec Science | 15.27M |